02/20/2025
4:11 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
4:12 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
4:13 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
4:14 PM | Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
4:14 PM | BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NMRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/18/2025
3:30 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:30 PM | BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
3:51 PM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:10 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:01 PM | BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:33 PM | ARCH Venture Fund XII, L.P. (Filed by)
Neumora Therapeutics (Subject)
| Form SC 13D/A | |
11/12/2024
6:17 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
5:25 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:01 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:26 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:10 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:30 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:10 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
4:22 PM | Neumora Therapeutics (Filer)
| Form S-3ASR | |
09/19/2024
3:35 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:37 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:22 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:18 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
4:58 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:17 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
8:48 AM | Neumora Therapeutics (Subject)
Pinto Joshua (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
6:15 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:15 PM | FMR LLC (Filed by)
Neumora Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/08/2024
12:07 PM | FMR LLC (Filed by)
Neumora Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/28/2024
8:00 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy this AI Stock Before Elon’s Announcement (Ad) With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust.
This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record.
I've identified a company that is quietly enabling xAI's rapid growth. Click here to watch my presentation and learn how to invest today. |
05/07/2024
6:15 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
4:00 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
5:46 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:34 PM | Neumora Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
6:08 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free NMRA Stock Alerts